Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Nitrogen | HCID 947 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| Reactant | HCID 73211791 | HCID 73211791 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 86711497 | HCID 86711497 | — |
Reaction Steps
To a vial under N2 containing 5-(5-(3-bromobenzyl)-4-methyloxazol-2-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole (27 mg, 0.056 mmol), tris(dibenzylideneacetone)dipalladium (10 mg, 0.011 mmol), Xphos (11 mg, 0.022 mmol), and Cs2CO3 (37 mg, 0.11 mmol) was added dioxane (1 mL, degassed with N2) followed by 1-methylpiperazine (10 μL, 0.084 mmol). The vial was sealed and heated to 120° C. in a Biotage microwave reactor for 60 min. The mixture was cooled to room temperature, filtered (Celite), and concentrated under reduced pressure. The crude oil was purified by HPLC to provide an orange oil: (7.8 mg, 28%): 1H NMR (600 MHz, DMSO-d6) δ ppm 8.20 (d, J=8.8 Hz, 2H), 7.61 (d, J=8.4 Hz, 2H), 7.23 (t, J=8.0 Hz, 1H), 6.95 (s, 1H), 6.91 (app. dd, J=8.3 Hz, 2.4 Hz, 1H), 6.77 (d, J=7.5 Hz, 1H), 4.17 (s, 2H), 3.84 (d, J=13.6 Hz, 1H), 3.51 (d, J=12.0 Hz, 1H), 3.19-1.09 (m, 2H), 2.94 (t, J=12.6 Hz, 2H), 2.85 (s, 3H), 2.61 (app. t, J=1.9 Hz, 1H), 2.38 (app. t, J=1.9 Hz, 1H), 2.27 (s, 3H); MS (ES+) C25H24F3N5O3 requires: 499, found: 500 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09115120B2 |
|---|
| Source dataset | uspto-grants-2015_08 |
|---|
| ORD ID | ord-fdf93f9c593444468244ff8e6e7f19c6 |
|---|
| Source note | uspto-grants-2015_08 |
|---|